What does the GLP-1 taper planner actually show?

It projects your medication level over time under two strategies — stopping now, or stepping down through a reverse-titration schedule — using each drug's published elimination half-life. It also overlays commonly reported appetite-return timing so you can see roughly where hunger tends to shift relative to your own curve.

Is the taper planner a prescribed schedule I should follow?

No. It's an illustrative, educational projection, not a prescription. GLP-1 Coach does not recommend dose changes or a discontinuation timeline for you specifically — any real taper or stop decision should be made with your prescriber.

Do I need an account to use it?

No. The public version at /tools/taper-planner works with no sign-up — enter your medication and current dose and it generates the projection immediately. The in-app version, available to GLP-1 Coach users, auto-fills from your actual logged dose history instead of manual entry.

How is this different from the taper articles already on the blog?

The existing articles explain the science and convention behind tapering — what the FDA labels say (or don't), why prescribers taper anyway, and what a typical step-down schedule looks like. This tool takes that same information and turns it into a projection built around your specific medication and dose, rather than a generic table.

Does the tool account for my actual dose history if I'm a GLP-1 Coach user?

Yes. Logged in, the planner pulls your most recently confirmed dose from your check-ins rather than asking you to re-enter it, so the projection reflects what you've actually taken.

Introducing the GLP-1 Taper Planner: See Your Own Decay Curve

Written by the GLP-1 Coach editorial team. Last updated August 26, 2026.

We've written before about why there's no official taper schedule for any GLP-1 and about what the pharmacokinetics say about when appetite actually comes back. Both articles keep landing on the same limitation: a table is a generic answer to a question that's actually personal — your medication, your current dose, and your own timeline.

So we built a tool that answers it with a picture instead of a table: the GLP-1 taper planner.

What the tool actually does

Enter your medication (Ozempic, Wegovy, Mounjaro, or Zepbound) and your current dose, and the planner projects your medication level forward under two strategies:

Stop now — the drug decays along its published elimination half-life starting today.
Step down — the same reverse-titration convention described in our cold-turkey-vs-step-down article, stepping back through your medication's dose levels before reaching zero.

Both curves render side by side, so instead of reading "semaglutide takes about 5 weeks to clear" as an abstract fact, you see what that means for your dose specifically — and how much longer the step-down strategy stretches the transition out.

Layered on top are milestone callouts marking commonly reported appetite-return windows, anchored to your projected last-dose date. These aren't a personalized prediction — no published trial has tracked subjective appetite return week by week, a limitation we're explicit about both in the tool and in the appetite-timeline article — but they give you a rough sense of where on your own curve hunger has tended to shift for others.

Why a curve beats a table

A generic taper table tells you what a step-down schedule looks like in the abstract. It doesn't tell you where you are on it, how much of the decision is actually about the number of weeks involved for your specific starting dose, or how the two strategies compare side by side rather than one at a time.

Seeing your own curve makes a few things concrete that are easy to miss in a table:

How much longer a step-down actually takes for your specific dose — the gap between "stop now" and "step down" is bigger at higher doses and smaller near the bottom of the titration range.
Where the appetite-return window falls relative to each strategy — under a step-down, that window is stretched and softened rather than compressed into the first couple of weeks.
What "almost cleared" looks like on your own timeline, rather than as a generic "5 weeks" or "3–4 weeks" figure that doesn't map to a specific date.

Who it's for

Anyone weighing the taper-vs-cold-turkey decision from our existing article on the subject — but also anyone who's already decided to stop and just wants a realistic sense of the transition ahead, whichever way they're doing it. It's not a tool for people who haven't yet discussed stopping with their prescriber; it's a tool for making that conversation more concrete once it's already on the table.

It's illustrative, not a prescription

This is worth repeating in the same terms we use in the tool itself: this is an illustrative projection, not a prescribed schedule. GLP-1 Coach does not recommend dose changes or a specific discontinuation timeline for you. The projection is grounded in each medication's published elimination half-life and the reverse-titration convention detailed in our taper article — it is not derived from a trial that tested tapering against abrupt cessation, because no such trial exists. Any real decision about tapering, stopping, or changing your GLP-1 dose belongs with the prescriber managing your care.

Try it — no account needed

The public version lives at /tools/taper-planner and works with no sign-up: enter your medication and current dose, and the projection generates immediately.

If you're already tracking with GLP-1 Coach, the in-app version goes a step further — it auto-fills from your most recently confirmed dose in your check-in history, so you're not re-entering numbers you've already logged. You'll find it linked from your dashboard, or directly at /guide/taper-planner once you're signed in.

Final Thoughts

The taper-vs-cold-turkey decision was never really about missing information — the half-lives are published, the convention is well understood, and we'd already written about both in detail. What was missing was a way to see it mapped onto your own situation instead of reading it as someone else's table. That's what this tool is for.

If you haven't already, read why there's no official taper protocol and how prescribers think about it anyway and what the pharmacokinetics say about when appetite actually returns — the planner is built directly on both. And whichever strategy you land on, the muscle-loss-after-stopping piece is a reminder that the habit stack you carry into the transition matters more than the shape of the taper itself.

Related:

This article is educational and not a substitute for medical advice. The taper planner is an illustrative tool, not a prescribed schedule — decisions about tapering, stopping, or changing any GLP-1 medication should be made with the prescriber managing your care.

Sources: WHO Global Guideline on GLP-1 Medicines for Obesity, December 2025; Wegovy prescribing information, FDA; Zepbound prescribing information, Eli Lilly.